Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivatives

References

• Morphy R, Kay C, Rankovic Z. From magic bullets to designed multiple ligands. Drug Discov Today 2004;9:641–51.
   PubMed Web of Science ®Google Scholar
• Cryer B. NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality. Am J Gastroenterol 2005;100:1694–5.
   PubMed Web of Science ®Google Scholar
• Go MF. Drug injury in the upper gastrointestinal tract: nonsteroidal anti-inflammatory drugs. Gastrointest Endosc Clin N Am 2006;16:83–97.
   PubMedGoogle Scholar
• James MW, Hawkey CJ. Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in human gastrointestinal tract. Br J Clin Pharmacol 2003;56:146–55.
   PubMed Web of Science ®Google Scholar
• Lozzaroni M, Porro GB. Gastrointestinal side-effects of traditional anti-inflammatory drugs and new formulations. Aliment Pharmacol Ther 2004;20(2):48–58.
   Web of Science ®Google Scholar
• Naesdal J, Brown K. NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options. Drug Saf 2006;29:119–32.
   PubMed Web of Science ®Google Scholar
• Mounier G, Guy C, Berthoux F, Beyens MN, Ratrema M, Ollagnier M. Severe renal adverse events with arylcarboxylic non-steroidal anti-inflammatory drugs: results of an eight-year French national survey. Therapie 2006;61:255–66.
   PubMed Web of Science ®Google Scholar
• Schneider V, Levesque LE, Zhang B, Hutchinson T, Brophy JM. Association of selective and conventional nonsteroidal anti-inflammatory drugs with acute renal failure: a population-based nested case-control analysis. Am J Epidemiol 2006;164:881–9.
   PubMed Web of Science ®Google Scholar
• Zadrazil J. Nonsteroidal antiinflammatory drugs and kidney. Vnitr Lek 2006;52:686–90.
   PubMedGoogle Scholar
• Adebayo D, Bjarnason I. Is non-steroidal anti-inflammatory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J 2006;82:186–91.
   PubMed Web of Science ®Google Scholar
• Thomsen RW, Riis A, Munk EM, Norgaard M, Christensen S, Sorensen HT. 30-Day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: a population based study. Am J Gastroenterol 2006;101:2704–10.
   PubMed Web of Science ®Google Scholar
• Dogne JM, Supuran CT, Pratico D. Adverse cardiovascular effects of the coxibs. J Med Chem 2005;48:2251–7.
   PubMed Web of Science ®Google Scholar
• Mann NS. NO-aspirin. Gastroenterology 2003;125:1918–19.
   PubMed Web of Science ®Google Scholar
• Keeble JE, Moore PK. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidalanti-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol 2002;137:295–310.
   PubMed Web of Science ®Google Scholar
• Rehse K, Brehme F.New NO donors with antithrombotic and vasodilating activities, Part 27. Azide oximes and 1-hydroxytetrazoles. Arch Pharm Pharm Med Chem 2000;333:157–61.
   PubMed Web of Science ®Google Scholar
• Bias P, Buchner A, Klesser B, Laufer S. The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial. Am J Gastroenterol 2004;99:611–18.
   PubMed Web of Science ®Google Scholar
• Doggrell SA. The safety of lumiracoxib when used in the treatment of arthritis. Expert Opin Pharmacother 2005;6:347–50.
   PubMed Web of Science ®Google Scholar
• Velazquez C, Rao PN, McDonald R, Knaus EE. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents. Bioorg Med Chem 2005;13:2749–57.
   PubMed Web of Science ®Google Scholar
• Hunt RH, Barkun AN, Baron D, Bombardier C, Bursey FR, Marshall JR, et al. Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents. Can J Gastroenterol 2002;16:231–40.
   PubMed Web of Science ®Google Scholar
• Omar FA, Mahfouz NM, Rahman MA. Design, synthesis and anti-inflammatory activity of some 1,3,4-oxadiazole derivatives. Eur J Med Chem 1996;31:819–25.
   PubMed Web of Science ®Google Scholar
• Vogel AI. Text Book of Practical Organic Chemistry. New York: Longman Scientific & Technical, 1994:458, 1161.
   Google Scholar
• Mohd Amir, Kumar S. Synthesis and evaluation of anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation properties of ibuprofen derivatives. Acta Pharm 2007;57:31–45.
   PubMedGoogle Scholar
• Bhandari SV, Bothara KG, Raut MK. Design, synthesis, and evaluation of anti-inflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofinac acid as nonulcerogenic derivatives. Bioorg Med Chem 2008;16:1822–31.
   PubMed Web of Science ®Google Scholar
• Shrivastava SK, Nema A, Shrivastava SD. Conventional as well as microwave assisted synthesis of some new N9-[hydrazinoacetyl-(2-oxo-3-chloro-4-substituted aryl azetidine)]-carbazoles: antifungal and antibacterial studies. Indian J Chem 2008;47B:606–12.
   Google Scholar
• Abadi HA, Gehan HH, Asmaa A. Synthesis of novel 4-substituted-7-trifluoro methylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents. Bioorg Med Chem 2005;13:5759–65.
   PubMed Web of Science ®Google Scholar
• Winter CA, Risley EA, Nuss GN. Carrageenan induced edema in hind paw of the rats as an assay for anti-inflammatory drugs. Proc Soc Exp Biol 1962;111:544–7.
   PubMed Web of Science ®Google Scholar
• Koster R, Anderson M, De Beer EJ. Acetic acid for analgesic screening. Fed Proc 1959;18:412.
   Google Scholar
• Cioli V, Putzolu S, Rossi V, Sorza Barcellona P, Corradino C. The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol Appl Pharmacol 1979;50:283–9.
   PubMed Web of Science ®Google Scholar
• Fidalgo SS, Lacave MI, Illanes M, Motilva V. Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing. Effect of a selective cox-2 inhibitor <http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1J-4DNRXR4-2&_user=8570523&_coverDate=11%2F28%2F2004&_rdoc=23&_fmt=high&_orig=browse&_srch=doc-info%28%23toc%234892%232004%23994949998%23529595%23FLA%23display%23Volume%29&_cdi=4892&_sort=d&_docanchor=&_ct=33&_acct=C000107336&_version=1&_urlVersion=0&_userid=8570523&md5=ced063171e366758dc95cf5a7f921ef0>. Eur J Pharmacol 2004;505:187–94.
   PubMed Web of Science ®Google Scholar
• Palaska E, Sahin G, Kelicen P, Durlu N, Altinok G. Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco 2002;57:101–7.
   PubMedGoogle Scholar